Skip to content

ResMed

US · RMD #644 by market cap Listed 1970
225.98 +5.29 +2.40%
Live - 5344 symbols - heartbeat 78s ago · 2026-10-08 08:33
Pre-market 225.98 0.00%
After-hours 225.98 0.00%
Overnight 224.90 -0.48%
Market cap
31.78B
P/B
4.83
EPS
10.43
Reader sentiment Are you bullish or bearish on RMD?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Stifel Maintains ResMed(RMD.US) With Hold Rating
    Market Newswire · 2026/9/25
  • Company notice
    8-K: Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
    SEC · 2025/10/31
  • Company notice
    ResMed Inc: LR 1.15.3 Compliance
    ASX · 2026/8/28
  • Citi Maintains ResMed(RMD.US) With Hold Rating, Raises Target Price to $240
    Market Newswire · 2026/9/10
  • Rating change
    Rothschild & Co Redburn Initiates ResMed(RMD.US) With Hold Rating, Announces Target Price $230
    Market Newswire · 2026/8/19
  • Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. -- Barrons.com
    Barron's · 2026/9/16
  • Company notice
    8-K: Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
    SEC · 2026/5/1
  • Rating change
    Ord Minnett Remains a Buy on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
    TipRanks · 2026/8/10
  • RBC Capital Upgrades ResMed(RMD.US) to Buy Rating, Raises Target Price to $262
    Market Newswire · 2026/9/15
  • Rating change
    Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Gets a Buy From Canaccord Genuity
    TipRanks · 2026/9/29
  • KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $267
    Market Newswire · 2026/8/31
  • Company notice
    8-K: Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
    SEC · 2026/8/7
  • Rating change
    ResMed Price Target Raised 0.4% to A$46.80/Share by Macquarie
    Dow Jones · 2026/8/10
  • Company notice
    8-K: Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
    SEC · 2026/1/30
  • Rating change
    Macquarie Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
    TipRanks · 2026/8/10
  • Rating change
    J.P. Morgan Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
    TipRanks · 2026/8/12
  • Rating change
    Jarden Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
    TipRanks · 2026/8/12
  • Rating change
    Mizuho Securities Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $235
    Market Newswire · 2026/8/12
  • Rating change
    Citi Sticks to Their Hold Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
    TipRanks · 2026/9/10
  • Rating change
    Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Gets a Hold From Citi
    TipRanks · 2026/9/24

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:33:46 · For reference only, not investment advice and not tailored to your situation.